Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Bitmine buys 35,138 ETH for $59M, nearing 5% of Ethereum supply with second-largest crypto treasury.

Market News
25 Jun 2026
Crypto Briefing
View Source
Bullish
pluang ai news

Bitmine Immersion Technologies acquired 35,138 Ethereum tokens for about $59 million, bringing its total holdings to approximately 5.67 million ETH, or around 4.7% of Ethereum's circulating supply. Led by Tom Lee, the company aims to control 5% of ETH supply and benefits from staking yields of about 2.7%-2.8%, generating substantial annual income. Bitmine is now the second-largest corporate crypto holder after Strategy Inc., and its moves signal strong institutional interest in Ethereum. Investors should watch Bitmine's stock premium or discount to net asset value as a key indicator of Ethereum exposure risk and reward.

More News

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...

Company Fundamentals
Neutral
1 hour ago
Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...

Company Fundamentals
Neutral
1 hour ago
Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...

Market News
Neutral
1 hour ago
Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...

Market News
Neutral
1 hour ago
Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App